What is it about?
The availability of intellectual property rights for inventions involving personalized medicine is of paramount concern to the biotechnology industry. However, several decisions by the US Supreme Court and Federal Circuit adversely affected those rights.
Featured Image
Why is it important?
The Federal Circuit's recent decision in CellzDirect provides guidance on how to protect inventions directed to personalized medicine
Read the Original
This page is a summary of: CellzDirect gives new hope for patent protection for personalized medicine in the USA, Pharmaceutical Patent Analyst, July 2017, Future Science,
DOI: 10.4155/ppa-2017-0011.
You can read the full text:
Contributors
The following have contributed to this page
